| Name | Value |
|---|---|
| Revenues | 21.8M |
| Cost of Revenue | 17.3M |
| Gross Profit | 4.5M |
| Operating Expense | 5.4M |
| Operating I/L | -1.0M |
| Other Income/Expense | -2.2M |
| Interest Income | 0.1M |
| Pretax | -3.2M |
| Income Tax Expense | 0.0M |
| Net Income/Loss | -3.2M |
Recro Pharma, Inc. is a contract development and manufacturing organization specializing in the development, manufacturing, and packaging of therapeutic dosage forms, primarily in small molecule therapeutic development. The company offers a wide range of products including oral solid doses, sterile injectables, oral liquids, tablets, topicals, liquid/powder filled capsules, ophthalmic droppers, liposomes, and nano/microparticles. Additionally, it provides services in aseptic fill/finish, lyophilization, packaging, and logistics. Recro Pharma, Inc. generates revenue by providing these products and services to pharmaceutical companies for the development and production of various therapeutic medications.